Yasuhiro Yamauchi to Retrospective Studies
This is a "connection" page, showing publications Yasuhiro Yamauchi has written about Retrospective Studies.
Connection Strength
1.082
-
Hiraishi Y, Jo T, Michihata N, Hasegawa W, Sakamoto Y, Urushiyama H, Matsui H, Fushimi K, Nagase T, Yasunaga H, Yamauchi Y. Hospital Volume and Mortality following Diagnostic Bronchoscopy in Lung Cancer Patients: Data from a National Inpatient Database in Japan. Respiration. 2019; 97(3):264-272.
Score: 0.107
-
Urushiyama H, Jo T, Yasunaga H, Michihata N, Matsui H, Hasegawa W, Takeshima H, Sakamoto Y, Hiraishi Y, Mitani A, Fushimi K, Nagase T, Yamauchi Y. Oral fluorouracil vs vinorelbine plus cisplatin as adjuvant chemotherapy for stage II-IIIA non-small cell lung cancer: Propensity score-matched and instrumental variable analyses. Cancer Med. 2018 10; 7(10):4863-4869.
Score: 0.105
-
Jo T, Yasunaga H, Michihata N, Sasabuchi Y, Hasegawa W, Takeshima H, Sakamoto Y, Matsui H, Fushimi K, Nagase T, Yamauchi Y. Influence of Parkinsonism on outcomes of elderly pneumonia patients. Parkinsonism Relat Disord. 2018 09; 54:25-29.
Score: 0.103
-
Yamauchi Y, Yasunaga H, Sakamoto Y, Hasegawa W, Takeshima H, Urushiyama H, Jo T, Matsui H, Fushimi K, Nagase T. Mortality associated with bone fractures in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016; 11:2335-2340.
Score: 0.092
-
Yamauchi Y, Yasunaga H, Hasegawa W, Sakamoto Y, Takeshima H, Jo T, Matsui H, Fushimi K, Nagase T. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016; 11:1403-11.
Score: 0.091
-
Yamauchi Y, Yasunaga H, Matsui H, Hasegawa W, Jo T, Takami K, Fushimi K, Nagase T. Comparison of clinical characteristics and outcomes between aspiration pneumonia and community-acquired pneumonia in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2015 Jul 08; 15:69.
Score: 0.085
-
Yamauchi Y, Yasunaga H, Matsui H, Hasegawa W, Jo T, Takami K, Fushimi K, Nagase T. Comparison of in-hospital mortality in patients with COPD, asthma and asthma-COPD overlap exacerbations. Respirology. 2015 Aug; 20(6):940-6.
Score: 0.084
-
Yamauchi Y, Hasegawa W, Yasunaga H, Sunohara M, Jo T, Takami K, Matsui H, Fushimi K, Nagase T. Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan. Int J Chron Obstruct Pulmon Dis. 2014; 9:1337-46.
Score: 0.081
-
Jo T, Michihata N, Yamana H, Morita K, Ishimaru M, Yamauchi Y, Hasegawa W, Urushiyama H, Uda K, Matsui H, Fushimi K, Yasunaga H, Nagase T. Risk of drug-induced interstitial lung disease in hospitalised patients: a nested case-control study. Thorax. 2021 12; 76(12):1193-1199.
Score: 0.032
-
Ando T, Kawashima M, Jo T, Masuda K, Yamauchi Y, Tanaka G, Kage H, Suzukawa M, Nagai H, Matsui H, Fushimi K, Yasunaga H, Nagase T. Early Arterial Embolization and Mortality in Mechanically Ventilated Patients With Hemoptysis: A Nationwide Retrospective Cohort Study. Crit Care Med. 2020 10; 48(10):1480-1486.
Score: 0.030
-
Mikami Y, Jo T, Matsuzaki H, Ishimori T, Saito M, Sakamoto Y, Yamauchi Y, Takai D, Yatomi Y, Nagase T. Preoperative intervention with long-acting bronchodilators for the reduction of postoperative pulmonary complications in untreated patients with obstructive lung disease. Clin Respir J. 2020 Feb; 14(2):92-101.
Score: 0.029
-
Ikeda T, Yamauchi Y, Uchida K, Oba K, Nagase T, Yamada Y. Reference value for expiratory time constant calculated from the maximal expiratory flow-volume curve. BMC Pulm Med. 2019 Nov 11; 19(1):208.
Score: 0.029
-
Jo T, Michihata N, Yamana H, Sasabuchi Y, Matsui H, Urushiyama H, Mitani A, Yamauchi Y, Fushimi K, Nagase T, Yasunaga H. Reduction in exacerbation of COPD in patients of advanced age using the Japanese Kampo medicine Dai-kenchu-to: a retrospective cohort study. Int J Chron Obstruct Pulmon Dis. 2019; 14:129-139.
Score: 0.027
-
Mitani A, Jo T, Yasunaga H, Sakamoto Y, Hasegawa W, Urushiyama H, Yamauchi Y, Matsui H, Fushimi K, Nagase T. Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy. Anticancer Drugs. 2018 07; 29(6):560-564.
Score: 0.026
-
Jo T, Yasunaga H, Sasabuchi Y, Michihata N, Morita K, Yamauchi Y, Hasegawa W, Takeshima H, Sakamoto Y, Matsui H, Fushimi K, Nagase T. Association between dementia and discharge status in patients hospitalized with pneumonia. BMC Pulm Med. 2017 Oct 06; 17(1):128.
Score: 0.025
-
Shinno Y, Kage H, Chino H, Inaba A, Arakawa S, Noguchi S, Amano Y, Yamauchi Y, Tanaka G, Nagase T. Old age and underlying interstitial abnormalities are risk factors for development of ARDS after pleurodesis using limited amount of large particle size talc. Respirology. 2018 01; 23(1):55-59.
Score: 0.025
-
Hasegawa W, Yamauchi Y, Yasunaga H, Takeshima H, Sakamoto Y, Jo T, Sasabuchi Y, Matsui H, Fushimi K, Nagase T. Prognostic nomogram for inpatients with asthma exacerbation. BMC Pulm Med. 2017 Aug 04; 17(1):108.
Score: 0.024
-
Sakamoto Y, Yamauchi Y, Yasunaga H, Takeshima H, Hasegawa W, Jo T, Sasabuchi Y, Matsui H, Fushimi K, Nagase T. Development of a nomogram for predicting in-hospital mortality of patients with exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017; 12:1605-1611.
Score: 0.024
-
Sakamoto Y, Yamauchi Y, Yasunaga H, Takeshima H, Hasegawa W, Jo T, Matsui H, Fushimi K, Nagase T. Guidelines-concordant empiric antimicrobial therapy and mortality in patients with severe community-acquired pneumonia requiring mechanical ventilation. Respir Investig. 2017 Jan; 55(1):39-44.
Score: 0.023
-
Hasegawa W, Yamauchi Y, Yasunaga H, Sunohara M, Jo T, Matsui H, Fushimi K, Takami K, Nagase T. Clinical features of 280 hospitalized patients with lymphangioleiomyomatosis in Japan. Respirology. 2015 Jan; 20(1):160-5.
Score: 0.020
-
Hasegawa W, Yamauchi Y, Yasunaga H, Sunohara M, Jo T, Matsui H, Fushimi K, Takami K, Nagase T. Factors affecting mortality following emergency admission for chronic obstructive pulmonary disease. BMC Pulm Med. 2014 Sep 24; 14:151.
Score: 0.020